Capecitabine improved outcomes for breast cancer patients with disease after presurge

[News]

Treatment with the chemotherapy agent capecitabine increased disease-free survival for women with HER2-negative breast cancer that was not eliminated by presurgery chemotherapy, according to results...

More... (http://www.medicalnewstoday.com/releases/303873.php)